National Health (Paraplegic and Quadriplegic Program) Special Arrangement Amendment Instrument 2018 (No 1) (PB 24 of 2018) (Cth)
PB 24 of 2018
National Health (Paraplegic and Quadriplegic Program) Special Arrangement Amendment Instrument 2018 (No. 1)
National Health Act 1953
___________________________________________________________________________
I, LOUISE CLARKE, Assistant Secretary, Office of Health Technology Assessment Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Amendment Instrument under subsection 100(2) of the National Health Act 1953.
Dated 27 March 2018
LOUISE CLARKE
Assistant Secretary
Office of Health Technology Assessment Policy Branch
Technology Assessment and Access Division
Department of Health
___________________________________________________________________________
1 Name of Instrument
(1)This Instrument is the National Health (Paraplegic and Quadriplegic Program) Special Arrangement Amendment Instrument 2018 (No 1).
(2)This Instrument may also be cited as PB 24 of 2018.
2Commencement
This Instrument commences on 1 April 2018.
3 Amendments to National Health (Paraplegic and Quadriplegic Program) Special Arrangement 2010
Schedule 1 amends the National Health (Paraplegic and Quadriplegic Program) Special Arrangement 2010 (PB 118 of 2010).
Schedule 1 Amendments
Schedule 1, entry for Bisacodyl in the form Tablet, 5mg
omit:
Bisalax AS 400
Schedule 1, entry for Macrogol 3350 in the form Sachets containing powder for oral solution 13.125g with electrolytes, 30
(a)omit from the column headed “Maximum Amount” for the brand “Chemists’ Own Macrogol with Electrolytes”: 1 substitute: 2
(b)omit from the column headed “Maximum Amount” for the brand “Macrovic”: 1 substitute: 2
(c)omit from the column headed “Responsible Person” for the brand “Molaxole”: HM substitute: GO
Schedule 2
(a)omit:
HM Meda Pharmaceuticals Pty Ltd 59 155 308 679
(b)insert:
GO Mylan Health Pty Ltd 29 601 608 771
0
0
0